• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

罕见癌症患者未满足的支持性护理需求:系统评价。

Unmet supportive care needs of patients with rare cancer: A systematic review.

机构信息

Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands.

Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands.

出版信息

Eur J Cancer Care (Engl). 2021 Nov;30(6):e13502. doi: 10.1111/ecc.13502. Epub 2021 Aug 18.

DOI:10.1111/ecc.13502
PMID:34409667
Abstract

OBJECTIVE

Patients with rare cancers may experience different unmet needs than those with common cancer. The objective of this systematic review was to (1) investigate unmet supportive care needs of rare cancer patients throughout the disease trajectory and (2) identify predictive factors for these unmet needs.

METHODS

PubMed, PsycINFO and CINAHL were searched for publications (January 2011 to March 2021) focusing on unmet needs of patients with rare cancer. Two reviewers independently selected studies, extracted data and performed quality assessment. Findings were synthesised.

RESULTS

The search yielded 4,598 articles, of which 59 articles met eligibility criteria and 57 were of medium or high quality. Rare cancer patients most frequently reported unmet needs in the healthcare system and information domain (up to 95%), followed by the psychological domain (up to 93%) and the physical and daily living domain (up to 80%). Unmet needs were mainly reported in the posttreatment phase. The most frequently identified predictors were higher anxiety, younger age and higher neuroticism.

CONCLUSION

Patients with rare cancer have unmet needs throughout their disease trajectory. Supportive care needs of rare cancer patients should be addressed individually, depending on the rare cancer subdomain and phase of disease and from diagnosis onwards.

摘要

目的

罕见癌症患者可能比常见癌症患者有更多的未满足需求。本系统评价的目的是:(1) 调查罕见癌症患者在疾病过程中未满足的支持性护理需求;(2) 确定这些未满足需求的预测因素。

方法

检索了 PubMed、PsycINFO 和 CINAHL 上的文献(2011 年 1 月至 2021 年 3 月),重点关注罕见癌症患者的未满足需求。两位评审员独立选择研究、提取数据并进行质量评估。结果进行了综合分析。

结果

搜索结果得到了 4598 篇文章,其中 59 篇符合入选标准,57 篇为中高质量。罕见癌症患者最常报告在医疗保健系统和信息领域存在未满足的需求(高达 95%),其次是心理领域(高达 93%)和身体及日常生活领域(高达 80%)。未满足的需求主要在治疗后阶段报告。最常被识别的预测因素是更高的焦虑、更年轻的年龄和更高的神经质。

结论

罕见癌症患者在疾病过程中存在未满足的需求。应根据罕见癌症亚组和疾病阶段以及从诊断开始,针对罕见癌症患者的个体情况来解决支持性护理需求。

相似文献

1
Unmet supportive care needs of patients with rare cancer: A systematic review.罕见癌症患者未满足的支持性护理需求:系统评价。
Eur J Cancer Care (Engl). 2021 Nov;30(6):e13502. doi: 10.1111/ecc.13502. Epub 2021 Aug 18.
2
Identifying the unmet supportive care needs of people affected by kidney cancer: a systematic review.识别肾癌患者未满足的支持性护理需求:一项系统评价
J Cancer Surviv. 2022 Dec;16(6):1279-1295. doi: 10.1007/s11764-021-01113-8. Epub 2021 Oct 1.
3
Unmet care needs of advanced cancer patients and their informal caregivers: a systematic review.晚期癌症患者及其非专业照护者的未满足护理需求:系统评价。
BMC Palliat Care. 2018 Jul 23;17(1):96. doi: 10.1186/s12904-018-0346-9.
4
Early palliative interventions for improving outcomes in people with a primary malignant brain tumour and their carers.早期姑息治疗干预对改善原发性脑恶性肿瘤患者及其照护者结局的影响。
Cochrane Database Syst Rev. 2022 Jan 6;1(1):CD013440. doi: 10.1002/14651858.CD013440.pub2.
5
What Are the Unmet Supportive Care Needs of People Affected by Cancer: An Umbrella Systematic Review.癌症患者未满足的支持性护理需求有哪些:伞式系统评价。
Semin Oncol Nurs. 2023 Jun;39(3):151353. doi: 10.1016/j.soncn.2022.151353. Epub 2022 Nov 23.
6
Home treatment for mental health problems: a systematic review.心理健康问题的居家治疗:一项系统综述
Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150.
7
Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.阿德福韦酯与聚乙二醇化干扰素α-2a治疗慢性乙型肝炎:系统评价与经济学评估
Health Technol Assess. 2006 Aug;10(28):iii-iv, xi-xiv, 1-183. doi: 10.3310/hta10280.
8
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
9
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.拓扑替康治疗卵巢癌的临床有效性和成本效益的快速系统评价。
Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280.
10
Music interventions for improving psychological and physical outcomes in people with cancer.音乐干预对改善癌症患者心理和生理结局的影响。
Cochrane Database Syst Rev. 2021 Oct 12;10(10):CD006911. doi: 10.1002/14651858.CD006911.pub4.

引用本文的文献

1
Symptoms, unmet needs, and quality of life in Erdheim-Chester disease: a longitudinal registry-based analysis.骨硬化性脂膜炎的症状、未满足的需求及生活质量:一项基于纵向注册研究的分析
Blood Adv. 2025 Sep 9;9(17):4415-4424. doi: 10.1182/bloodadvances.2024015659.
2
Assessing the impact of a self-guided digital intervention for fear of cancer recurrence (iConquerFear) in ovarian cancer survivors: a pilot randomised waitlist-controlled trial.评估一项针对卵巢癌幸存者癌症复发恐惧的自我引导式数字干预措施(“我战胜恐惧”)的效果:一项随机对照的试点等候名单试验。
BMC Cancer. 2025 Mar 23;25(1):527. doi: 10.1186/s12885-025-13639-6.
3
Prevalence and Associated Factors for Depression Among Patients With Sarcoma.
肉瘤患者中抑郁症的患病率及相关因素
JCO Oncol Pract. 2025 Mar 4:OP2400163. doi: 10.1200/OP.24.00163.
4
What do patients with a rare cancer living in rural, regional or remote areas and stakeholders want from a peer support program? A qualitative study.生活在农村、地区或偏远地区的罕见癌症患者及利益相关者对同伴支持项目有何期望?一项定性研究。
BMC Cancer. 2025 Feb 25;25(1):352. doi: 10.1186/s12885-025-13782-0.
5
Health-Related Quality of Life (HRQoL) Assessments in Research on Patients with Adult Rare Solid Cancers: A State-of-the-Art Review.成人罕见实体癌患者研究中的健康相关生活质量(HRQoL)评估:最新综述
Cancers (Basel). 2025 Jan 24;17(3):387. doi: 10.3390/cancers17030387.
6
Adding checkpoint inhibitors to first-line chemotherapy for NUT carcinoma patients.在NUT癌患者的一线化疗中添加检查点抑制剂。
NPJ Precis Oncol. 2025 Jan 25;9(1):26. doi: 10.1038/s41698-024-00768-7.
7
An Evaluation of Rare Cancer Policies in Europe: A Survey Among Healthcare Providers.欧洲罕见癌症政策评估:医疗服务提供者调查
Cancers (Basel). 2025 Jan 7;17(2):164. doi: 10.3390/cancers17020164.
8
A systematic review of peer support interventions to improve psychosocial functioning among cancer survivors: can findings be translated to survivors with a rare cancer living rurally?一项关于同伴支持干预措施以改善癌症幸存者心理社会功能的系统评价:研究结果能否应用于农村地区的罕见癌症幸存者?
Orphanet J Rare Dis. 2024 Dec 20;19(1):473. doi: 10.1186/s13023-024-03477-3.
9
Diagnostic trajectories of patients with rare cancer in the Netherlands: results from a nationwide cross-sectional survey.荷兰罕见癌症患者的诊断轨迹:一项全国性横断面调查的结果。
Support Care Cancer. 2024 Nov 19;32(12):807. doi: 10.1007/s00520-024-08998-y.
10
Addressing cancer survivors' information needs and satisfaction: a systematic review of potential intervention components for survivors with a rare cancer type.满足癌症幸存者的信息需求和满意度:对罕见癌症类型幸存者的潜在干预措施的系统评价。
Orphanet J Rare Dis. 2024 Oct 18;19(1):387. doi: 10.1186/s13023-024-03403-7.